- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06362473
Lipidtransportforstyrrelse italiensk genetisk registrering (LIPIGEN) (LIPIGEN)
LIPIGEN is an observational study involving Italian physicians and researchers in the field of diseases related to blood lipid levels. This study aims to improve the diagnosis and treatment of people with familial dyslipidaemias, including very common conditions such as familial hypercholesterolaemia (FH) and less common ones such as familial chylomicronidaemic syndrome (FCS).
What does the study do?
It collects information on Italian patients with Familial Hypercholesterolaemia (FH), following them in their normal clinical examination without adding extra procedures.
It uses the data collected to further our understanding of diseases such as familial hypercholesterolaemia, examining how it is diagnosed clinically and by genetic testing, and evaluating the effectiveness of different treatments.
It seeks to identify the genetic mutations that cause familial hypercholesterolaemia and other dyslipidaemias, helping to choose the most effective treatments.
It evaluates the impact of long-term treatments and patient adherence to medication, as well as monitoring the incidence of cardiovascular events and other important outcomes.
Who can participate?
The study is aimed at people of all ages, from children to adults, with familial hypercholesterolaemia or other genetic dyslipidaemia.
More than 50 centres throughout Italy are involved, making the study accessible to many.
What does participation entail?
Participants will continue with their normal clinical practice.
Data such as family history, personal clinical findings and genetic information will be collected, without additional procedures.
For some, further evaluations, such as ultrasounds, may be required to better study their condition.
The LIPIGEN study not only helps to better understand diseases related to high cholesterol but also aims to improve patients' lives through more precise diagnosis and personalised treatments.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Manuela Casula, PhD
- Telefonnummer: +390250318428
- E-post: manuela.casula@unimi.it
Studiesteder
-
-
Milano
-
Sesto San Giovanni, Milano, Italia, 20099
- Rekruttering
- IRCCS Multimedica
-
Ta kontakt med:
- Liliana Grigore, MD
- Telefonnummer: 00390224209593
- E-post: lipigen@sisa.it
-
Hovedetterforsker:
- Liliana Grigore, MD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Subjects with molecular or clinical diagnosis of genetic dyslipidemia of any age or sex.
Beskrivelse
Inclusion Criteria:
- Molecular or clinical diagnosis of genetic dyslipidemia
- Informed consent signed
Exclusion Criteria:
- None
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: CROSS_SECTIONAL
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Lipid profile of patients with genetic dyslipidemia
Tidsramme: At baseline and through study completion up to 20 years
|
Lipid profile of patients with molecular or clinical diagnosis of genetic dyslipidemia:
|
At baseline and through study completion up to 20 years
|
|
Genetic profile of patients with genetic dyslipidemia
Tidsramme: At baseline evaluation
|
Genetic profile of patients with molecular or clinical diagnosis of genetic dyslipidemia:
|
At baseline evaluation
|
Samarbeidspartnere og etterforskere
Etterforskere
- Studiestol: Alberico L Catapano, PhD, Fondazione S.I.S.A.
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Metabolisme, medfødte feil
- Metabolske sykdommer
- Hyperlipidemier
- Dyslipidemier
- Lipidmetabolismeforstyrrelser
- Lipidmetabolisme, medfødte feil
- Hyperlipoproteinemier
- Medfødte, arvelige og neonatale sykdommer og abnormiteter
- Ernæringsmessige og metabolske sykdommer
- Genetiske sykdommer, medfødte
- Hyperlipoproteinemi type II
Andre studie-ID-numre
- LIPIGEN-001
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .